|Northwestern University, B.A||1988|
Ms. Kamdar joined Domain Associates in 2005 and became a Principal in 2006. Present board memberships include Nuon Therapeutics, Obalon Therapeutics, ROX Medical, Sonexa Therapeutics, Syndax Pharmaceuticals, Tragara Pharmaceuticals, as well as observer status at Achaogen, BiPar Sciences, Corthera, GenVault, Lipothera and SkinMedica. Ms. Kamdar serves as an advisory board member to Eric Topolâ€™s NIH supported Clinical and Translational Science Award for Scripps Medicine. Additionally, Ms. Kamdar serves as an Advisory Board Member for Evolvence India Life Sciences Fund, a private equity fund providing growth capital to Indian pharmaceutical and biotechnology companies. From 2003-2004, Ms. Kamdar was a Kauffman Fellow with MPM Capital. Prior to joining MPM, Ms. Kamdar was a Research Director at Novartis. She built and led a research team that focused on the biology, genetics and genomics of model organisms to uncover small molecules that modulated signaling pathway networks. Ms. Kamdar is a founder of Aryzun Pharmaceuticals, a biotech company utilizing protein-protein interaction mapping for small molecule discovery with an initial focus on anti-infectives and oncology. Ms. Kamdar is the author of ten papers as well as the inventor on seven patents.